UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 77

Sortiert nach

Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression

Brain Structure and Function, 2008-09, Vol.213 (1-2), p.93-118

2008

Volltextzugriff (PDF)

Replication of Scopolamine's Antidepressant Efficacy in Major Depressive Disorder: A Randomized, Placebo-Controlled Clinical Trial

Biological psychiatry (1969), 2010-03, Vol.67 (5), p.432-438

2010

Volltextzugriff (PDF)

Antidepressant Effects of the Muscarinic Cholinergic Receptor Antagonist Scopolamine: A Review

Biological psychiatry (1969), 2013-06, Vol.73 (12), p.1156-1163

2013

Volltextzugriff (PDF)

Human Biomarkers of Rapid Antidepressant Effects

Biological psychiatry (1969), 2013-06, Vol.73 (12), p.1142-1155

2013

Volltextzugriff (PDF)

Distributed and Overlapping Representations of Faces and Objects in Ventral Temporal Cortex

Science (American Association for the Advancement of Science), 2001-09, Vol.293 (5539), p.2425-2430

2001

Volltextzugriff (PDF)

Neural basis of abnormal response to negative feedback in unmedicated mood disorders

NeuroImage (Orlando, Fla.), 2008-09, Vol.42 (3), p.1118-1126

2008

Volltextzugriff (PDF)

Antidepressant treatment history as a predictor of response to scopolamine: clinical implications

Journal of affective disorders, 2014-06, Vol.162, p.39-42

2014

Volltextzugriff (PDF)

Ketamine normalizes brain activity during emotionally valenced attentional processing in depression

NeuroImage clinical, 2018-01, Vol.20, p.92-101

2018

Volltextzugriff (PDF)

Beyond Sensory Images: Object-Based Representation in the Human Ventral Pathway

Proceedings of the National Academy of Sciences - PNAS, 2004-04, Vol.101 (15), p.5658-5663

2004

Volltextzugriff (PDF)

The extended functional neuroanatomy of emotional processing biases for masked faces in major depressive disorder

PloS one, 2012-10, Vol.7 (10), p.e46439-e46439

2012

Volltextzugriff (PDF)

Changes in the neural correlates of implicit emotional face processing during antidepressant treatment in major depressive disorder

The international journal of neuropsychopharmacology, 2013-11, Vol.16 (10), p.2195-2208

2013

Volltextzugriff (PDF)

Association between subcortical volumes and verbal memory in unmedicated depressed patients and healthy controls

Neuropsychologia, 2012-07, Vol.50 (9), p.2348-2355

2012

Volltextzugriff (PDF)

Cholinergic Enhancement and Increased Selectivity of Perceptual Processing during Working Memory

Science (American Association for the Advancement of Science), 2000-12, Vol.290 (5500), p.2315-2319

2000

Volltextzugriff (PDF)

Dissociation of Face-Selective Cortical Responses by Attention

Proceedings of the National Academy of Sciences - PNAS, 2006-01, Vol.103 (4), p.1065-1070

2006

Volltextzugriff (PDF)

Improvement in suicidal ideation after ketamine infusion: Relationship to reductions in depression and anxiety

Journal of psychiatric research, 2014-11, Vol.58, p.161-166

2014

Volltextzugriff (PDF)

Relationship Between Dissociation and Antidepressant Effects of Esketamine Nasal Spray in Patients With Treatment-Resistant Depression

The international journal of neuropsychopharmacology, 2022-04, Vol.25 (4), p.269-279

2022

Volltextzugriff (PDF)

Scopolamine Produces Larger Antidepressant and Antianxiety Effects in Women Than in Men

Neuropsychopharmacology (New York, N.Y.), 2010-11, Vol.35 (12), p.2479-2488

2010

Volltextzugriff (PDF)

The prominent role of stimulus processing: cholinergic function and dysfunction in cognition

Current opinion in neurology, 2011-08, Vol.24 (4), p.364-370

2011

Volltextzugriff (PDF)

Group differences in MEG-ICA derived resting state networks: Application to major depressive disorder

NeuroImage (Orlando, Fla.), 2015-09, Vol.118, p.1-12

2015

Volltextzugriff (PDF)

Potential of pretreatment neural activity in the visual cortex during emotional processing to predict treatment response to scopolamine in major depressive disorder

JAMA psychiatry (Chicago, Ill.), 2013-03, Vol.70 (3), p.280

2013

Volltextzugriff (PDF)

Effects of Mu-Opiate Receptor Gene Polymorphism rs1799971 (A118G) on the Antidepressant and Dissociation Responses in Esketamine Nasal Spray Clinical Trials

The international journal of neuropsychopharmacology, 2020-12, Vol.23 (9), p.549-558

2020

Volltextzugriff (PDF)

Cholinergic enhancement reduces functional connectivity and BOLD variability in visual extrastriate cortex during selective attention

Neuropharmacology, 2013-01, Vol.64 (1), p.305-313

2013

Volltextzugriff (PDF)

Nocturnal Wakefulness Is Associated With Next-Day Suicidal Ideation in Major Depressive Disorder and Bipolar Disorder

The journal of clinical psychiatry, 2016-06, Vol.77 (6), p.825

2016

Volltextzugriff (PDF)

Selective Effects of Cholinergic Modulation on Task Performance during Selective Attention

Neuropsychopharmacology (New York, N.Y.), 2008-03, Vol.33 (4), p.913-923

2008

Volltextzugriff (PDF)

Ketamine Alters Electrophysiological Responses to Emotional Faces in Major Depressive Disorder

Journal of affective disorders, 2021-01, Vol.279, p.239-249

2021

Volltextzugriff (PDF)

1 – 25 von 77

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(72)
Mit Volltextzugriff
(67)

Publikationsform

Artikel
(74)
Buchkapitel
(3)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(64)
Humans
(61)
Life Sciences & Biomedicine
(59)
Male
(49)
Female
(47)
Neurosciences & Neurology
(38)
Adult
(36)
Psychiatry
(35)
Neurosciences
(34)
Biological And Medical Sciences
(28)
Middle Aged
(28)
Depression
(24)
Medical Sciences
(24)
Psychology. Psychoanalysis. Psychiatry
(18)
Brain Mapping
(17)
Depressive Disorder, Major - Drug Therapy
(17)
Aged
(16)
Magnetic Resonance Imaging
(16)
Neurology
(16)
Antidepressive Agents - Therapeutic Use
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression

Replication of Scopolamine's Antidepressant Efficacy in Major Depressive Disorder: A Randomized, Placebo-Controlled Clinical Trial

Antidepressant Effects of the Muscarinic Cholinergic Receptor Antagonist Scopolamine: A Review

Human Biomarkers of Rapid Antidepressant Effects

Distributed and Overlapping Representations of Faces and Objects in Ventral Temporal Cortex

Neural basis of abnormal response to negative feedback in unmedicated mood disorders

Antidepressant treatment history as a predictor of response to scopolamine: clinical implications

Ketamine normalizes brain activity during emotionally valenced attentional processing in depression

Beyond Sensory Images: Object-Based Representation in the Human Ventral Pathway

The extended functional neuroanatomy of emotional processing biases for masked faces in major depressive disorder

Changes in the neural correlates of implicit emotional face processing during antidepressant treatment in major depressive disorder

Association between subcortical volumes and verbal memory in unmedicated depressed patients and healthy controls

Cholinergic Enhancement and Increased Selectivity of Perceptual Processing during Working Memory

Dissociation of Face-Selective Cortical Responses by Attention

Improvement in suicidal ideation after ketamine infusion: Relationship to reductions in depression and anxiety

Relationship Between Dissociation and Antidepressant Effects of Esketamine Nasal Spray in Patients With Treatment-Resistant Depression

Scopolamine Produces Larger Antidepressant and Antianxiety Effects in Women Than in Men

The prominent role of stimulus processing: cholinergic function and dysfunction in cognition

Group differences in MEG-ICA derived resting state networks: Application to major depressive disorder

Potential of pretreatment neural activity in the visual cortex during emotional processing to predict treatment response to scopolamine in major depressive disorder

Effects of Mu-Opiate Receptor Gene Polymorphism rs1799971 (A118G) on the Antidepressant and Dissociation Responses in Esketamine Nasal Spray Clinical Trials

Cholinergic enhancement reduces functional connectivity and BOLD variability in visual extrastriate cortex during selective attention

Nocturnal Wakefulness Is Associated With Next-Day Suicidal Ideation in Major Depressive Disorder and Bipolar Disorder

Selective Effects of Cholinergic Modulation on Task Performance during Selective Attention

Ketamine Alters Electrophysiological Responses to Emotional Faces in Major Depressive Disorder

Suchergebnisse filtern